Literature DB >> 34078609

The development of a functional human small intestinal epithelium model for drug absorption.

Ohman Kwon1, Kwang Bo Jung1,2, Kyeong-Ryoon Lee3, Ye Seul Son1,2, Hana Lee1,2, Jong-Jin Kim1,2, Kwangho Kim1, Seop Lee3,4, Yoo-Kyung Song3, Jaeeun Jung1,2, Kunhyang Park1, Dae-Soo Kim1,2, Myung Jin Son1,2, Mi-Ok Lee1,2, Tae-Su Han1, Hyun-Soo Cho1,2, Soo Jin Oh5, Haeun Chung6,7, Sang-Heon Kim6,7, Kyung-Sook Chung1,2, Janghwan Kim8,2, Cho-Rok Jung8,2, Mi-Young Son8,2.   

Abstract

Advanced technologies are required for generating human intestinal epithelial cells (hIECs) harboring cellular diversity and functionalities to predict oral drug absorption in humans and study normal intestinal epithelial physiology. We developed a reproducible two-step protocol to induce human pluripotent stem cells to differentiate into highly expandable hIEC progenitors and a functional hIEC monolayer exhibiting intestinal molecular features, cell type diversity, and high activities of intestinal transporters and metabolic enzymes such as cytochrome P450 3A4 (CYP3A4). Functional hIECs are more suitable for predicting compounds metabolized by CYP3A4 and absorbed in the intestine than Caco-2 cells. This system is a step toward the transition from three-dimensional (3D) intestinal organoids to 2D hIEC monolayers without compromising cellular diversity and function. A physiologically relevant hIEC model offers a novel platform for creating patient-specific assays and support translational applications, thereby bridging the gap between 3D and 2D culture models of the intestine.
Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34078609     DOI: 10.1126/sciadv.abh1586

Source DB:  PubMed          Journal:  Sci Adv        ISSN: 2375-2548            Impact factor:   14.136


  6 in total

1.  Organoid-derived intestinal epithelial cells are a suitable model for preclinical toxicology and pharmacokinetic studies.

Authors:  Yu Takahashi; Makoto Noguchi; Yu Inoue; Shintaro Sato; Makoto Shimizu; Hirotatsu Kojima; Takayoshi Okabe; Hiroshi Kiyono; Yoshio Yamauchi; Ryuichiro Sato
Journal:  iScience       Date:  2022-06-07

2.  Generation of Highly Expandable Intestinal Spheroids Composed of Stem Cells.

Authors:  Ohman Kwon; Won Dong Yu; Ye Seul Son; Kwang Bo Jung; Hana Lee; Mi-Young Son
Journal:  Int J Stem Cells       Date:  2022-02-28       Impact factor: 2.500

3.  Navigating Through Cell-Based In vitro Models Available for Prediction of Intestinal Permeability and Metabolism: Are We Ready for 3D?

Authors:  Yesenia L Franco; Lais Da Silva; Rodrigo Cristofoletti
Journal:  AAPS J       Date:  2021-11-22       Impact factor: 3.603

4.  Human gut-microbiome-derived propionate coordinates proteasomal degradation via HECTD2 upregulation to target EHMT2 in colorectal cancer.

Authors:  Tae Young Ryu; Kwangho Kim; Tae-Su Han; Mi-Ok Lee; Jinkwon Lee; Jinhyeon Choi; Kwang Bo Jung; Eun-Jeong Jeong; Da Mi An; Cho-Rok Jung; Jung Hwa Lim; Jaeeun Jung; Kunhyang Park; Moo-Seung Lee; Mi-Young Kim; Soo Jin Oh; Keun Hur; Ryuji Hamamoto; Doo-Sang Park; Dae-Soo Kim; Mi-Young Son; Hyun-Soo Cho
Journal:  ISME J       Date:  2022-01-01       Impact factor: 11.217

5.  A Scalable Human Intestinal Planar Culture Offers Opportunities for High-throughput Drug Testing.

Authors:  Subhasree Kumar; Nan Gao
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2022-05-28

6.  Limosilactobacillus reuteri DS0384 promotes intestinal epithelial maturation via the postbiotic effect in human intestinal organoids and infant mice.

Authors:  Hana Lee; Kwang Bo Jung; Ohman Kwon; Ye Seul Son; Eunho Choi; Won Dong Yu; Naeun Son; Jun Hyoung Jeon; Hana Jo; Haneol Yang; Yeong Rak Son; Chan-Seok Yun; Hyun-Soo Cho; Sang Kyu Kim; Dae-Soo Kim; Doo-Sang Park; Mi-Young Son
Journal:  Gut Microbes       Date:  2022 Jan-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.